CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 93 filers reported holding CATALYST BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,830,000 | -18.7% | 2,635,014 | -14.3% | 4.93% | -29.3% |
| Q2 2021 | $13,321,000 | +7.9% | 3,076,376 | +25.6% | 6.97% | +4.4% |
| Q1 2021 | $12,349,000 | +134.5% | 2,450,193 | +193.6% | 6.67% | +65.5% |
| Q4 2020 | $5,265,000 | -13.2% | 834,449 | -40.9% | 4.03% | -36.1% |
| Q3 2020 | $6,069,000 | +88.8% | 1,411,412 | +157.8% | 6.31% | +1.4% |
| Q2 2020 | $3,214,000 | -27.8% | 547,541 | -46.3% | 6.22% | +32.2% |
| Q1 2020 | $4,454,000 | +112.8% | 1,019,196 | +231.7% | 4.71% | +222.8% |
| Q4 2019 | $2,093,000 | – | 307,287 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |